As previously reported, our results showed that the MKK4 rs3826392 variant operates as a protective factor for CRC; however, for the first time, these results also reveal that the rs3809728 variant is associated with an increased risk of CRC. Here, MAP2K4 is linked to colorectal carcinoma.